Search companies or stocks...
MYNZMainz Biomed B.V.
At close · 22 May 2026, 04:35 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics.…
Current stock price of Mainz Biomed B.V. (MYNZ) stock is $3.590. The stock price is +0.84% higher in the session. The intraday range can be seen from this page. Volume of Mainz Biomed B.V. (MYNZ) stock is 6.00M.
Last updated at 22 May 2026, 04:35 pm.
The stock price of Mainz Biomed B.V. (MYNZ) can change with earnings, company news, and overall market sentiment. Mainz Biomed B.V. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Mainz Biomed B.V. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MYNZ on this page is -0.68. EPS on this page is -5.28. Compare those figures with peers and growth expectations before deciding if the current Mainz Biomed B.V. price is justified.
Historical performance for Mainz Biomed B.V. (MYNZ) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MYNZ reacted to past earnings and market events.
Buying Mainz Biomed B.V. (MYNZ) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
